Despite the promise of TLR agonists as potential anticancer agents, few have reached the clinics due to concerns related to cytokine release syndrome and limited efficacy. Intratumoral mRNA encoding ...

At the close of trading in Asia on Tuesday, the yellow metal ended up by just over 26% for the year at $2,626.80/ozt; one of its highest annual appreciation rate this century and its biggest since ...